This is a standard insider Form 144 reflecting planned sales to cover withholding taxes from restricted stock vesting. The dollar amount is small and not indicative of bearish conviction. No action warranted — continue to monitor for unplanned open-market insider sales via Form 4.
Price Chart
Executive Summary
Board member John Oyler filed a Form 144 to sell 4,940 ADSs (~$1.3M at the prevailing market price) from restricted stock vesting under a registered plan. The sale appears to be a routine, planned disposition to cover tax obligations from equity vesting, not a discretionary insider sale. Given the small relative size and the pre-arranged nature, this filing is neutral with minimal market impact.
Key Facts
- Filer: John Oyler, a director and officer of BeOne Medicines Ltd.
- Proposed sale: 4,940 ADSs, estimated aggregate market value ~$1.34 million
- Shares acquired on 06/05/2026 via restricted stock vesting under a registered plan
- Sale to execute through Morgan Stanley Smith Barney LLC Executive Financial Services
- Filing date: 2026-06-08; trade date anticipated same day
Financial Impact
Proposed sale of ~$1.34M in ADSs from equity vesting; represents 0% of shares outstanding (no data for precise float calculation but sum is immaterial for a pharmaceutical firm of this size)
Risk Factors
- None material from this filing alone
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005747 |
| Document: 0001950047-26-005747-index.html | 0001950047-26-005747 |
| Document: 0001950047-26-005747.txt | 0001950047-26-005747 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 8, 2026 20w ago | 144 | $21.95 $21.95 | · 0.00% | ▼ −4.08% | $21.95 (−0.00%) |
May 6, 2026 24w ago | 8-K | $22.50 $21.95 | ▼ −2.48% | ▼ −4.54% | $21.95 (−2.48%) |
Apr 14, 2026 28w ago | 8-K | $22.50 $21.95 | ▼ −2.48% | ▼ −11.00% | $21.95 (−2.48%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers